The role of IL-12 and TGF-β1 in the pathophysiology of major depressive disorder

Kyung Min Lee, Yong Ku Kim

Research output: Contribution to journalArticle

96 Citations (Scopus)

Abstract

It has been postulated that major depression may be accompanied by significant changes in cell-mediated and humoral immunity related to the pathophysiology or pathogenesis of that illness. We explored the role of 2 cytokines, IL-12 and TGF-β1, which represent the cytokines of the Th1 and Th3 types, in the pathophysiology of major depressive disorder (MDD). Cytokine levels were measured in 30 major depressed patients at the time of admission and 6 weeks after effective antidepressant treatment; levels were measured once in 30 normal controls. At the time of admission, TGF-β1 levels of MDD patients showed no differences from normal controls, but IL-12 was significantly higher than in normal controls. However, the IL-12/TGF-β1 (Th1/Th3) ratios of depressed patients were not different from those of controls. In MDD patients, IL-12 values were significantly decreased after treatment, while TGF-β1 levels were significantly increased. IL-12/TGF-β1 ratios of patients were significantly decreased after treatment compared with before treatment. There were no significant correlations between changes in the cytokine levels and changes in scores representing the severity of depression. These findings suggest that major depression is accompanied by immune activation during the acute depressed state, and antidepressant treatments have anti-inflammatory effects.

Original languageEnglish
Pages (from-to)1298-1304
Number of pages7
JournalInternational Immunopharmacology
Volume6
Issue number8
DOIs
Publication statusPublished - 2006 Aug 1

Fingerprint

Major Depressive Disorder
Interleukin-12
Cytokines
Depression
Antidepressive Agents
Therapeutics
Humoral Immunity
Cellular Immunity
Anti-Inflammatory Agents

Keywords

  • Cytokine
  • IL-12
  • Major depression
  • Psychoimmunology
  • TGF

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Pharmacology

Cite this

The role of IL-12 and TGF-β1 in the pathophysiology of major depressive disorder. / Lee, Kyung Min; Kim, Yong Ku.

In: International Immunopharmacology, Vol. 6, No. 8, 01.08.2006, p. 1298-1304.

Research output: Contribution to journalArticle

@article{5a3d26b41c4941f39186360c45d293c9,
title = "The role of IL-12 and TGF-β1 in the pathophysiology of major depressive disorder",
abstract = "It has been postulated that major depression may be accompanied by significant changes in cell-mediated and humoral immunity related to the pathophysiology or pathogenesis of that illness. We explored the role of 2 cytokines, IL-12 and TGF-β1, which represent the cytokines of the Th1 and Th3 types, in the pathophysiology of major depressive disorder (MDD). Cytokine levels were measured in 30 major depressed patients at the time of admission and 6 weeks after effective antidepressant treatment; levels were measured once in 30 normal controls. At the time of admission, TGF-β1 levels of MDD patients showed no differences from normal controls, but IL-12 was significantly higher than in normal controls. However, the IL-12/TGF-β1 (Th1/Th3) ratios of depressed patients were not different from those of controls. In MDD patients, IL-12 values were significantly decreased after treatment, while TGF-β1 levels were significantly increased. IL-12/TGF-β1 ratios of patients were significantly decreased after treatment compared with before treatment. There were no significant correlations between changes in the cytokine levels and changes in scores representing the severity of depression. These findings suggest that major depression is accompanied by immune activation during the acute depressed state, and antidepressant treatments have anti-inflammatory effects.",
keywords = "Cytokine, IL-12, Major depression, Psychoimmunology, TGF",
author = "Lee, {Kyung Min} and Kim, {Yong Ku}",
year = "2006",
month = "8",
day = "1",
doi = "10.1016/j.intimp.2006.03.015",
language = "English",
volume = "6",
pages = "1298--1304",
journal = "International Immunopharmacology",
issn = "1567-5769",
publisher = "Elsevier",
number = "8",

}

TY - JOUR

T1 - The role of IL-12 and TGF-β1 in the pathophysiology of major depressive disorder

AU - Lee, Kyung Min

AU - Kim, Yong Ku

PY - 2006/8/1

Y1 - 2006/8/1

N2 - It has been postulated that major depression may be accompanied by significant changes in cell-mediated and humoral immunity related to the pathophysiology or pathogenesis of that illness. We explored the role of 2 cytokines, IL-12 and TGF-β1, which represent the cytokines of the Th1 and Th3 types, in the pathophysiology of major depressive disorder (MDD). Cytokine levels were measured in 30 major depressed patients at the time of admission and 6 weeks after effective antidepressant treatment; levels were measured once in 30 normal controls. At the time of admission, TGF-β1 levels of MDD patients showed no differences from normal controls, but IL-12 was significantly higher than in normal controls. However, the IL-12/TGF-β1 (Th1/Th3) ratios of depressed patients were not different from those of controls. In MDD patients, IL-12 values were significantly decreased after treatment, while TGF-β1 levels were significantly increased. IL-12/TGF-β1 ratios of patients were significantly decreased after treatment compared with before treatment. There were no significant correlations between changes in the cytokine levels and changes in scores representing the severity of depression. These findings suggest that major depression is accompanied by immune activation during the acute depressed state, and antidepressant treatments have anti-inflammatory effects.

AB - It has been postulated that major depression may be accompanied by significant changes in cell-mediated and humoral immunity related to the pathophysiology or pathogenesis of that illness. We explored the role of 2 cytokines, IL-12 and TGF-β1, which represent the cytokines of the Th1 and Th3 types, in the pathophysiology of major depressive disorder (MDD). Cytokine levels were measured in 30 major depressed patients at the time of admission and 6 weeks after effective antidepressant treatment; levels were measured once in 30 normal controls. At the time of admission, TGF-β1 levels of MDD patients showed no differences from normal controls, but IL-12 was significantly higher than in normal controls. However, the IL-12/TGF-β1 (Th1/Th3) ratios of depressed patients were not different from those of controls. In MDD patients, IL-12 values were significantly decreased after treatment, while TGF-β1 levels were significantly increased. IL-12/TGF-β1 ratios of patients were significantly decreased after treatment compared with before treatment. There were no significant correlations between changes in the cytokine levels and changes in scores representing the severity of depression. These findings suggest that major depression is accompanied by immune activation during the acute depressed state, and antidepressant treatments have anti-inflammatory effects.

KW - Cytokine

KW - IL-12

KW - Major depression

KW - Psychoimmunology

KW - TGF

UR - http://www.scopus.com/inward/record.url?scp=33745162262&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745162262&partnerID=8YFLogxK

U2 - 10.1016/j.intimp.2006.03.015

DO - 10.1016/j.intimp.2006.03.015

M3 - Article

C2 - 16782542

AN - SCOPUS:33745162262

VL - 6

SP - 1298

EP - 1304

JO - International Immunopharmacology

JF - International Immunopharmacology

SN - 1567-5769

IS - 8

ER -